Purified Serum IgG from a Patient with Anti-IgLON5 Antibody Cause Long-Term Movement Disorders with Impaired Dopaminergic Pathways in Mice.

Gao, Yining; Li, Hongxia; Luo, Huoqing; Ni, You; Feng, Yifan; He, Lu; Zhou, Qinming; Hu, Ji; Chen, Sheng

Gao, Yining; Li, Hongxia; Luo, Huoqing; Ni, You; Feng, Yifan; He, Lu; Zhou, Qinming; Hu, Ji; Chen, Sheng.

Afiliação

Gao Y; Department of Neurology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200023, China.
Li H; Department of Neurology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200023, China.
Luo H; School of Life Science and Technology, ShanghaiTech University, Shanghai 201210, China.
Ni Y; Department of Neurology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200023, China.
Feng Y; School of Life Science and Technology, ShanghaiTech University, Shanghai 201210, China.
He L; Department of Neurology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200023, China.
Zhou Q; Department of Neurology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200023, China.
Hu J; School of Life Science and Technology, ShanghaiTech University, Shanghai 201210, China.
Chen S; Co-Innovation Center of Neuroregeneration, Nantong University, Nantong 226007, China.

Biomedicines ; 11(9)2023 Sep 07.

Article em En | MEDLINE | ID: mdl-37760924

Palavras-chave

anti-IgLON5 disease; dopaminergic pathways; movement disorders; neuropathology; substantia nigra pars compacta

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Revista: Biomedicines Ano de publicação: 2023 Tipo de documento: Article País de afiliação: China País de publicação: Suíça

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google